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Abstract
Background
Cancer patients are frequently admitted to hospital due to acute conditions or refractory
symptoms. This occurs through the emergency departments and requires medical oncolo-
gists to take an active role. The use of acute-care hospital increases in the last months
of life.
Patients andmethods
We aimed to describe the admissions to a medical oncology inpatient service within a
16-month period with respect to patients and tumor characteristics, and the outcome of the
hospital stay.
Results
672 admissions of 454 patients were analysed. The majority of admissions were urgent
(74.1%), and were due to uncontrolled symptoms (79.6%). Among the chief complaints,
dyspnoea occurred in 15.7%, pain in 15.2%, and neurological symptoms in 14.5%. The ma-
jority of the hospitalizations resulted in discharge to home (60.6%); in 26.5% the patient
died and in 11.0% was transferred to a hospice. Admissions due to symptoms correlated
with a longer hospital stay and a higher incidence of in-hospital death.
Conclusion
We suggest that hospital use is not necessarily a sign of inappropriately aggressive care: in-
patient care is probably an unavoidable step in the cancer trajectory. Optimization of inpa-
tient supportive procedures should be a specific task of modern medical oncology.
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Background
The landscape of the medical needs of cancer patients has undergone deep changes in the last
decades that have not been followed by rapid changes in health care services. Cancer concerns
an increasingly elderly population, often affected by multiple comorbidities [1]. Active treat-
ments are offered for the majority of the natural history of the disease, and the exclusive pallia-
tive care phase has been shortened [2]. For some primary tumours available treatments are so
aggressive that complex supportive care is needed: examples are chemo-radiotherapy treat-
ments for head and neck, oesophageal and lung tumours, and chemotherapy for haematologi-
cal diseases. On the other hand, while progressively improving in their organization and
population coverage, home care services are not able to provide all the required assistance out-
side hospitals. Societal changes partially account for this greater need of care centralization.
The consequence is that cancer patients frequently need hospital admission in acute care set-
tings [3–6]. This progressive shift has two main consequences: 1) urgent admission is becom-
ing a frequent modality of admission [4]. The more easy way to hospital seems to be the
emergency department, which is open all day long, is able to provide comprehensive care and
can rapidly refer the patient to the appropriate department. 2) The oncological wards, once in-
tended to provide specialist care and complex active treatments, are frequently used for symp-
tom management and for terminal care. While this trend has been attributed to inappropriate
aggressiveness, especially in the last phase of life, or to an inadequate territorial coverage by
palliative cares services [3], we hypothesized that the request of hospital admission and of
acute care is independent from external factors and is somewhat unavoidable. As part of an in-
ternal quality improvement project we surveyed all the admissions in the onco-hematological
ward of our General Hospital during a 16-month period. We were interested in understanding
the characteristics of the patients admitted, the main reasons of admission, the interventions
administered during their hospital stay, and the modalities of discharge.
Patients and Methods
The Valle d’Aosta area, a special status Region in north-western Italy, has about 130,000 inhab-
itants (39.4/Km2). It is served by a single, 436-bed hospital that includes all surgical specialties,
the emergency department, the intensive care unit and a radiotherapy unit with a tomotherapy
equipment. The medical oncology department has an in-hospital acute care 12-bed ward. The
inpatient oncology service admits patients with both solid and haematological tumours. As an
internal policy the inpatient service is not used for chemotherapy administration unless the pa-
tient is at risk of medical complications (for example germ cell tumours or lymphoma with
bulky disease undergoing their first treatment). The regional Palliative Care system includes a
7-bed hospice department together with home care and ambulatory services. Ambulatory pa-
tients are referred to the Palliative Care service as soon as there is not further indication to
anti-cancer drugs and are fully cared for at home. Reasons for exclusion from home care are
the lack of a stable caregiver and a concurrent severe medical acute condition. Intravenous
treatments, oxygen and blood products can be delivered at home in the whole Region. Cancer
patients referred to the emergency department are usually admitted to the oncological depart-
ment unless they report conditions unrelated to cancer. A meeting with Palliative Care physi-
cians is conducted twice-a-week in order to optimize in-hospital supportive care, select
patients for hospice referral and arrange discharge for those able to be cared for at home.
All patients admitted to the General Valle d’Aosta Hospital inpatient oncology ward be-
tween August 1 2011 and December 31 2012, were included. Data were collected retrospective-
ly and retrieved consecutively from the electronic medical records. Assessed patient
characteristics included age, sex and site of primary cancer. The chief complaint at admission
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was recorded, together with the final diagnosis. Symptoms were clustered into 8 categories:
breathlessness, pain, fever, intestinal obstruction, other digestive symptoms (nausea and vomit-
ing, jaundice, diarrhea, dysphagia, etc.), neurological symptoms (mainly related to brain metas-
tases or meningeal carcinomatosis), general symptoms (such as fatigue and cachexia) and
cardiovascular symptoms (such as those related to deep vein thrombosis, pericardial effusion,
heart failure). During hospitalization, information on the number and type of imaging studies,
procedures, and antitumor interventions as well as length of stay and whether the admission
was a repeated episode was collected. The modality of discharge was also recorded. The ethic
committee of the “Azienda USL della Valle d'Aosta” approved this retrospective study and
waived the requirement for informed consent. Patient informations were anonymized and de-
identified prior to analysis. Data management has been conducted according to the principles
expressed in the Declaration of Helsinki. All collected variables were described with simple sta-
tistics, such as medians and ranges, and the differences between groups were tested using the
2-sided Pearson Chi-square test, Fisher exact test, or Kruskal-Wallis test, as appropriate, with
p<0.05 considered statistically significant. Data were analysed using the IBM SPSS Statistics
for Windows, version 14.0 (IBM Corp., Armonk, NY).
Results
Patient characteristics at admission are reported in Table 1. 672 admissions of 452 patients
were performed in the examined period. While 297 patients were admitted once, 113 were ad-
mitted twice, 28 three times and 14 four or more times. 217 of the admissions (32,2%) occurred
after at least one previous admission. Median time from one admission to the subsequent one
Table 1. Patient characteristics.
Number %
Number of admissions per patient
One 299 66.1%
Two 115 25.4%
Three 28 6.1%
Four or more 11 2.4%
Sex
Male 258 56.9%
Female 195 43.0%
Age
Median age 69.2
Range 26–92
< 70 238 52.5%
 70 215 47.4%
Site of primary
Digestive tract 130 28.6%
Lung 114 25.1%
Hematologic 91 20.0%
Breast 33 7.2%
Urological 25 5.5%
Gynecological 20 4.4%
Other 30 6.6%
*the prevalent symptom at the time of admission was recorded.
doi:10.1371/journal.pone.0120827.t001
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was 6,8 weeks (range 1 to 80 weeks). In 19 (8,7%) and 58 (26,7%) cases the time from the subse-
quent admissions was 2 weeks or less and 4 weeks or less, respectively.
258 of the cases were males (56.9%). 215 patients were aged 70 or older (47.4%). Three can-
cer types accounted for the vast majority of admitted patients (73.7%): digestive tract (28.6%),
lung (25.1%) and haematological (20.0%).
Characteristics of admissions are detailed in Table 2. Patients were admitted with the pur-
pose of performing complex diagnostic or therapeutic procedures in 19.8% of the cases. In all
other cases (80.2%) a prevalent symptom was the cause of admission. Among the admissions
due to symptoms, the chief complaint was breathlessness in 15.7%, pain in 15.2% and
Table 2. Features of admissions.
Number %
Reason for admission
Cancer diagnosis or treatment 133 19.8%
Symptom* 539 80.2%
Dyspnea 85 15.7%
Pain 82 15.2%
Neurological 78 14.5%
Fever 72 13.3%
Digestive tract (vomiting, jaundice. . .) 72 13.3%
Intestinal obstruction 67 12.4%
General (asthenia, malaise. . .) 66 12.2%
Cardiovascular 17 3.1%
Modality of admission
Programmed 83 12.4%
Transferred from other units 91 13.5%
Urgent 498 74.1%
Diagnosis
Tumor-related condition 499 74.3%
Treatment-related toxicity 51 7.6%
Infection 95 14.1%
Vascular event 27 4.0%
Treatment
Medical supportive measures only 382 56.8%
Chemotherapy 51 7.6%
Invasive procedures 224 33.3%
Radiotherapy 15 2.2%
Length of stay
Mean (days) 12.1
Median (days) 9.0
Range 0–66
 7 days 282 42.0
> 7 days 390 58.0
Discharge
At home 407 60.6%
In-hospital death 178 26.5%
Hospice or long-term medical care 87 12.9%
*the prevalent symptom at the time of admission was recorded.
doi:10.1371/journal.pone.0120827.t002
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neurological symptoms in 14.5%. The most common modality of referral to the oncological
ward was an urgent admission (74.1%). A programmed admission or a transfer from other
units was far less common (12.4% and 13.5% respectively). Of the 498 urgent admissions, 329
(66.1%) were referred through the emergency department, while 169 (33.9%) were referred di-
rectly by the oncological or palliative care services.
In 74.3% of the admissions a condition that was directly related to tumor involvement was
diagnosed. A toxic event due to chemotherapy or chemo-radiotherapy was the cause of admis-
sion in 7.6%. Cancer-related Infections accounted for the 14,1% of the admissions while cardio-
vascular events were 4,0%.
During their hospital stay the majority of the patients received only medical supportive mea-
sures (such as antibiotics for infection or opiates for pain); 33.3% had a diagnostic or therapeutic
invasive procedure performed (such as thoracentesis for pleural effusion or biliary drainage for
obstruction). Only 9.8% of the patients received chemotherapy or radiotherapy. Median dura-
tion of hospital stay was 9.0 days, with 58.0% of the admissions having a duration of more than
7 days. One-hundred and seventy-eight admissions (26.5%) ended with in-hospital death and
another 12.9% was transferred to hospice.
When compared with admissions due to other reasons (Table 3), admissions due to symp-
toms were more frequently urgent, were longer, and resulted more frequently in the patient’s
death. When primary sites were analysed, digestive tract and lung tumors were more frequent
in the symptomatic population, while haematological cancers were prevalent in the admissions
of non-symptomatic patients.
Among the prevalent symptoms recorded at admission, pain, bowel obstruction and neuro-
logical symptoms caused the longest hospital stays (median number of days: 12.5, 11.0 and
11.0 respectively); breathlessness and general symptoms were more frequently associated with
hospital death (42.4 and 53.0%, respectively).
Discussion
The reported data clearly suggest that the medical oncology in-hospital ward is largely used for
symptom control in advanced cancer patients. This implies that admissions are frequently un-
scheduled, are repeated, are quite long and result in patients’ death or palliative care referral in
more than one third of cases. This scenario calls for a reflection on the skills required by medi-
cal oncologists and about the provision of a comprehensive care organization for
cancer patients.
The first issue to discuss is whether these data are reliable and how our findings compare
with those of other recent reported series. Several reports contribute to the growing awareness
that cancer care often involves dealing with acute conditions and symptom control. In a large
series of unscheduled ambulatory consultations to another Italian oncological service, pain
(27.7%), fatigue (17.6%), dyspnea (13.8%) and fever (11.5%) were the more frequent reasons
for the visit request [7]. Authors from the University of Wisconsin [8] reported on 149 un-
planned oncology admissions in 2010: in 66% of the cases patients were admitted due to symp-
toms and only in 3% for chemotherapy administration. Pain was the most common chief
compliant at admission (28%). Time of hospital stay increased as the number of admissions fi-
nalized to chemotherapy administration decreased in a ten-year period. The rate of referral to
hospice was 12% (compared to 18% in our series). These data indicate that the oncology in-
patient services are increasingly used for managing acute cancer-related conditions.
A second important issue is whether these admissions should be minimized through referral
of patients to other services or physicians. Could the improvement of cancer care reduce the
need for acute-hospital referral? Several lines of evidence suggest that the expansion of home
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care and hospice use does not reduce ED and ICU referrals nor hospitalization due to acute
conditions [9]. Cancer patients have unpredictable and complex medical needs that in some in-
stances can be managed only in the context of in-patient services. Researchers from the Dana
Farber Cancer Institute assessed avoidable hospitalization in 201 admissions of patients with
gastro-intestinal malignancies and, through a retrospective review of patients’ health records,
found that only 19% of the admissions could have been avoided [10]. Studies assessing emer-
gency department referral of oncological patients support the hypothesis that the majority are
unavoidable and result in hospital admission [11–12]. A recent comment about the increasing
rate of hospital readmission among Medicare patients [13] suggest “hospital-dependence” as a
common status of patients whose medical problems “cannot be managed outside the hospital”.
Although there may be some place for improvement, our data also support the hypothesis that
acute events cannot be managed outside hospital. Every effort to improve territorial services is
limited by the occurrence of acute events and the overlapping of multiple conditions (symp-
toms, organ failure, psychological discomfort, social frailties) that cannot be managed without
hospital care [14].
Table 3. Analysis of admissions divided per reason of admission: symptoms or other reasons.
Symptoms (539) Other reasons (133) P
Sex 0.483
Male 302 (56.0%) 79 (59.4%)
Female 237 (44.0%) 54 (40.6%)
Age 0.244
<70 294 (54.5%) 80 (60.2%)
>70 245 (45.5%) 53 (39.8%)
Site of primary 0.0001
Digestive tract 157 (29.1% 34 (25.6%)
Lung 136 (25.2%) 26 (19.5%)
Hematologic 94 (17.4%) 50 (37.6%)
Breast 44 (8.2%) 5 (3.8%)
Urological 32 (5.9%) 5 (3.8%)
Gynecological 29 (5.4%) 5 (3.8%)
Other 47 (8.7%) 8 (6.0%)
Length of stay 0.001
<7 days 210 (39.0%) 72 (54.1%)
>7 days 329 (61.0%) 61 (45.9%)
Modality of admission 0.0001
Programmed 33 (6.1%) 50 (37.6%)
Transferred 40 (7.4%) 51 (38.3%)
Urgent 466 (86.5%) 32 (24.1%)
Diagnosis 0.0001
Tumor-related condition 378 (70.1%) 121 (91.0%)
Non tumor-related condition 114 (21.2%) 8 (6.0%)
Treatment-related toxicity 47 (8.7%) 4 (3.0%)
Discharge 0.0001
At home 306 (56.8%) 101 (75.9%)
In-hospital death 162 (30.1%) 16 (12.0%)
Hospice or long-term medical care 71 (13.2%) 16 (12.0%)
doi:10.1371/journal.pone.0120827.t003
Hospital Admission of Cancer Patients
PLOS ONE | DOI:10.1371/journal.pone.0120827 March 26, 2015 6 / 10
At the present time, the theory that better home care causes reduced hospital use is not evi-
dence-based and proponents have not been able to demonstrate this relationship [11, 15].
Instead we propose that the treatment of acute events and refractory symptoms should be
considered a specific task of oncology services: improving quality of the cares provided, short-
ening the time to symptom control and appropriately using both medical and invasive treat-
ments are probably the aim of a modern oncology ward.
Admission of cancer patients through the emergency department may be viewed as uncom-
fortable due to the possibly long waiting times and clinical assessment provided by physicians
who do not usually take care of the patient. Moreover, partial patient knowledge could induce
inappropriately aggressive interventions. Anticipating the critical worsening of symptoms by
booking admission in advance and favouring direct admissions from home and ambulatory
services are probably two possible ways of improving patient care. In our series one out of
three admissions was driven without access to the ED, while in other series this practice seems
rare [15]. Providing an acute oncological consulting service could further improve this process
[7, 16]. However, in the majority of the cases, the need for timely, multiple laboratory and ra-
diological examinations and for a comprehensive, coordinated assessment make the emergency
department the only adequate response to the patients’ needs in complex conditions.
The final issue is whether the high rate of death in an acute care setting could be reduced. In
our series one third of admissions resulted in in-hospital death or hospice referral. Could these
patients have been more appropriately assisted at home or referred directly to a hospice? We
have already shown that prognostication in the context of an acute event is not straightforward
[17]. The frequency of hospitalization near the end of life has been shown to be increasing, and
has been included among the indicators of aggressive care, thus suggesting that there is an in-
verse relationship between the rate of hospital admission and the quality of palliative care orga-
nization [18]. However, studies assessing the influence of home palliative cares, while showing
significant differences in terms of place of death [19–20], did not find a reduction in hospital
admissions or emergency department visits [9, 21–22]. The majority of patients with cancer
still die in hospitals in several European countries [23] and hospitalization in the last period of
life is extremely common. An analysis of hospital use conducted in Ontario on more than
200.000 cancer patients who died between 1986 and 1998 found that less than 10% were not
admitted to hospital in the last 6 months of life and that the hospitalization rate dramatically
increased as death approached [24]. Similar data have also been found in European healthcare
systems [25–27]. This is in line with our opinion that complex symptoms or acute events can-
not be fully cared for by home services. Moreover home care is strictly dependent from the fa-
miliar and social environment: as the potential caregivers are progressively less able to take
care of their relatives (mainly due to socio-economic factors) the hospital becomes the only
possible solution for terminal care. For these reasons, focusing health care policy strictly on or-
ganizing end-of-life care at home may not decrease hospital referral of cancer patients [28] and
may not decrease costs of advanced cancer care [29].
We suggest that in-hospital care of symptoms and acute events should be improved in order
to provide prompt palliation and clinical stabilization. Afterwards, care should be kept on in
low-intensity structures. Flexibility of the system, with easy transitions from one care setting to
another, is probably the goal to be pursued, instead of closing the doors of hospitals to advanced
cancer patients or considering the referrals to the emergency departments as inappropriate.
Duration of in-hospital stay should be optimized through improved and faster symptom
control. In our experience longer stays were those in which admission was due to pain, bowel
obstruction and neurological symptoms. Although variable reasons could be implicated, we
support the hypothesis that adoption of evidence-based procedures may reduce the time to
symptom control.
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Some limitations of our study must be taken into account. As this is an evaluation of a small
Italian region, with a single oncological and palliative care unit, the data may not be fully gener-
alizable. For example the organization of home services and social support, and the formal and
informal rules applied in the hospital context could have influenced the results of our analysis,
although we have shown that comparable issues are reported in other contexts. Finally, the ret-
rospective nature of the study carries some inherent biases such as the incomplete recording of
some patient-related factors and the possible exclusion of a few cancer patients admitted to
other departments during the examined period.
In conclusion, the data shown in this report support the crucial role of oncologists in the
context of inpatient care. Competences and skills should be enhanced accordingly and should
be considered part of the specific place of oncology in cancer care [30]. Moreover we suggest
that hospitalization of cancer patients should be considered a necessary step in the trajectory of
the disease [31]; rather than considering hospitalization as avoidable or even inappropriate, we
should increase our efforts to assure rapid symptom control and prompt stabilization of
acute conditions.
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